LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Feb 11, 2022
Distillery Therapeutics
Simultaneously inhibiting ASM and activating GHSR for Alzheimer’s
Read More
BioCentury
|
Jan 31, 2020
Distillery Therapeutics
Targeting SMPD1 to treat norovirus
Read More
BioCentury
|
Sep 12, 2019
Preclinical News
Sept. 12 Preclinical Quick Takes: Stephen Quake newco reveals epigenomic platform; plus Personal Genome, Summit and Biolife4D
Read More
BioCentury
|
Sep 12, 2019
Distillery Therapeutics
SMPD1 gene therapy for Niemann-Pick disease type A
Read More
BioCentury
|
Aug 31, 2018
Financial News
Rakuten’s Mikitani leads Aspyrian's $150M series C
Read More
BioCentury
|
Aug 23, 2018
Financial News
Rakuten’s Mikitani leads Aspyrian's $150M series C
Read More
BioCentury
|
Jun 11, 2018
Preclinical News
Summit identifies two new classes of antibiotics
Read More
BioCentury
|
Jun 14, 2017
Translation in Brief
Connecting microbiome dots
Why bacteriophages could be considered human pathogens
Read More
BioCentury
|
Aug 22, 2016
Emerging Company Profile
Metal smithing
How Forge's metal-binding chemistry can tackle tough metalloenzyme targets
Read More
BioCentury
|
Jul 18, 2013
Targets & Mechanisms
Depressing sphingolipids
Read More
Items per page:
10
1 - 10 of 340